| Schedule of basic and diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net income (in thousands) |
|
$ |
168,960 |
|
$ |
167,602 |
|
$ |
472,064 |
|
$ |
467,870 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic |
|
|
29,751,713 |
|
|
31,615,110 |
|
|
30,901,788 |
|
|
31,588,740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
35,034 |
|
|
36,425 |
|
|
35,566 |
|
|
28,040 |
RSAs with market-based conditions |
|
|
38,187 |
|
|
31,918 |
|
|
38,840 |
|
|
25,606 |
RSAs with performance-based conditions |
|
|
11,297 |
|
|
17,663 |
|
|
15,735 |
|
|
16,223 |
Stock options |
|
|
89,169 |
|
|
87,696 |
|
|
91,928 |
|
|
86,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - diluted |
|
|
29,925,400 |
|
|
31,788,812 |
|
|
31,083,857 |
|
|
31,744,856 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share |
|
$ |
5.68 |
|
$ |
5.30 |
|
$ |
15.28 |
|
$ |
14.81 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share |
|
$ |
5.65 |
|
$ |
5.27 |
|
$ |
15.19 |
|
$ |
14.74 |
|
| Summary of shares excluded from the calculation of diluted income per share because their effect would have been anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Anti-dilutive common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
- |
|
|
- |
|
|
- |
|
|
3,721 |
|
RSAs with market-based conditions |
|
|
9,006 |
|
|
- |
|
|
7,341 |
|
|
2,978 |
|
RSAs with performance-based conditions |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Stock options |
|
|
- |
|
|
- |
|
|
- |
|
|
12,360 |
|
Total anti-dilutive common stock equivalents |
|
|
9,006 |
|
|
- |
|
|
7,341 |
|
|
19,059 |
|
|